Antonio Cubillo Gracián

3.9k citations
30 papers · 697 indexed · 1 hit paper · h-index 15
Topics
Colorectal Cancer Treatments and Studies (11 papers)Pancreatic and Hepatic Oncology Research (10 papers)Cancer Genomics and Diagnostics (8 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer Research
Partner nations
SpainUnited StatesItaly

In The Last Decade

Antonio Cubillo Gracián

29 papers receiving 690 citations

Hit Papers

CheckMate 040 cohort 5: A phase I/II study of nivolumab i...202120262022202420214080120

Peers

Antonio Cubillo Gracián
Comparison fields: 5 of 54
  • Oncology 439
  • Hepatology 308
  • Pulmonary and Respiratory Medicine 136
  • Epidemiology 125
  • Pathology and Forensic Medicine 119
Replace Yuji Eso with:
Yuji Eso Japan
Feng Wen China
Akhil Chopra Singapore
Andrea Palloni Italy
Monica Lencioni Italy
Ho-Yeong Lim South Korea
Adarsh Joshi United States
Á. Chopitea Spain
Michele Basso Italy
Javier Rodríguez Spain
Antonio Cubillo Gracián relative to Yuji Eso Japan Yuji Eso's profile →
Citations per field
00.5×
Yuji Eso · 1×
Citations per year

Countries citing papers authored by Antonio Cubillo Gracián

Since Specialization
Citations

This map shows the geographic impact of Antonio Cubillo Gracián's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Cubillo Gracián with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Cubillo Gracián more than expected).

Fields of papers citing papers by Antonio Cubillo Gracián

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Cubillo Gracián. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Cubillo Gracián. The network helps show where Antonio Cubillo Gracián may publish in the future.

Co-authorship network of co-authors of Antonio Cubillo Gracián

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Cubillo Gracián. A scholar is included among the top collaborators of Antonio Cubillo Gracián based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Cubillo Gracián. Antonio Cubillo Gracián is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 24
2 4
3 1
4 0
5 20
6 1
7 46
8 20
9
CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosisbreakdown →
141
10 42
11 21
12 36
13 79
14 47
15 22
16 31
17 20
18 7
19 2
20 4

About Antonio Cubillo Gracián

Antonio Cubillo Gracián is a scholar working on Oncology, Hepatology and Cancer Research, having authored 30 papers that have together received 697 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (11 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Cancer Genomics and Diagnostics (8 papers). The work is most often cited by research in Hepatology (308 citations), Oncology (439 citations) and Pathology and Forensic Medicine (119 citations). Antonio Cubillo Gracián has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Armando Santoro, Bruno Sangro, Jaclyn Neely, Ana Matilla, Su Pin Choo, Anthony B. El-Khoueiry, Mirelis Acosta-Rivera, Yun Shen, Marina Tschaika and Bassel F. El‐Rayes. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026